ahlam1399
05-29-2015, 11:38 PM
Bristol-Myers sues immu**therapy exec who left for AstraZeneca
NEW YORK (Reuters) - Bristol-Myers Squibb has sued a top cancer immu**therapy executive for violating confidentiality and **n-compete agreements after he left for direct competitor AstraZeneca, court documents show.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46c4ac69/sc/3/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/1/rc.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/1/rc.htm)
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/2/rc.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/2/rc.htm)
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/3/rc.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/3/rc.htm)
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2.htm)
http://adchoice.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/ach.img (http://adchoice.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/ach.htm)http://pi.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2t.imghttp://pi2.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=rSI0HbcgS_8:NDXrM**bj4E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rSI0HbcgS_8:NDXrM**bj4E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=rSI0HbcgS_8:NDXrM**bj4E:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rSI0HbcgS_8:NDXrM**bj4E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=rSI0HbcgS_8:NDXrM**bj4E:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/rSI0HbcgS_8
NEW YORK (Reuters) - Bristol-Myers Squibb has sued a top cancer immu**therapy executive for violating confidentiality and **n-compete agreements after he left for direct competitor AstraZeneca, court documents show.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46c4ac69/sc/3/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/1/rc.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/1/rc.htm)
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/2/rc.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/2/rc.htm)
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/3/rc.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/rc/3/rc.htm)
http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2.img (http://da.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2.htm)
http://adchoice.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/ach.img (http://adchoice.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/ach.htm)http://pi.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2t.imghttp://pi2.feedsportal.com/r/228858324522/u/49/f/654207/c/35217/s/46c4ac69/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=rSI0HbcgS_8:NDXrM**bj4E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rSI0HbcgS_8:NDXrM**bj4E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=rSI0HbcgS_8:NDXrM**bj4E:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rSI0HbcgS_8:NDXrM**bj4E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=rSI0HbcgS_8:NDXrM**bj4E:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/rSI0HbcgS_8